IL33 and immunoglobulin G4-related sclerosing disease: Inasmuch as such pDCs are localized in the pancreas of patients with AIP/IgG4-RD and the patients exhibit elevated serum concentrations of IFN-α and IL-33, this conclusion also applies to the pathogenesis of human AIP/IgG4-RD (3–5, 7).